Day: December 18, 2025

Trade Republic confirms decacorn status, following secondary share sale

Trade Republic confirms decacorn status, following secondary share sale German stock trading app Trade Republic has confirmed a €12.5 billion ($14.7bn) valuation, following a secondary share sale which saw Peter Thiel’s Founders Fund and Sequoia buy more shares. The new €12.5bn valuation propels Trade Republic to decacorn status (privately held company

Small business tech tips: A guide to getting more done with Zoom Workplace [Sponsored]

Small business tech tips: A guide to getting more done with Zoom Workplace [Sponsored] As a small business owner, you have to be scrappy. You need to find ways to break out in today’s crowded market — reach new audiences, automate processes, improve efficiencies, and do more with less —

Monzo wins European banking licence, as investors agitate for CEO return

Monzo wins European banking licence, as investors agitate for CEO return Monzo has been given the green light to expand across Europe, after winning a banking licence. The UK digital bank announced today that it has secured a European banking licence. The winning of the licence comes amid reports that well-known

The pickup counter Is food delivery’s blind spot — Pickpad is fixing it

The pickup counter Is food delivery’s blind spot — Pickpad is fixing it As digital ordering reshapes how people buy food, one of the biggest operational bottlenecks in restaurants isn’t the kitchen — it’s the pickup counter.   Off-premises orders now dominate in many markets, yet the moment where digital

Ankar lands $20M Series A to reinvent how Innovation becomes defensible IP

Ankar lands $20M Series A to reinvent how Innovation becomes defensible IP IP patent platform Ankar has raised a $20 million Series A round led by Atomico, with Index Ventures doubling down and Norrsken VC and Daphni participating.  This Series A brings Ankar’s total funding to $24 million. AI is

Following last month’s triple valuation, Quantum Systems deepens its autonomous focus through FERNRIDE deal

Following last month’s triple valuation, Quantum Systems deepens its autonomous focus through FERNRIDE deal Two German autonomous innovators merge today, as Quantum Systems, a developer of AI-powered unmanned systems, announced the acquisition of FERNRIDE to expand their leadership position from air and software intelligence to autonomous ground mobility, creating a

TV personalities and YouTubers back French accelerator Cube in €700k funding round

TV personalities and YouTubers back French accelerator Cube in €700k funding round Angers-based tech accelerator Cube, formerly known as Cube3, has closed a €700k funding round as it doubles down on its hybrid accelerator model that merges business support, financing, and media production. The company has attracted investment from a

Ukraine battlefield use underpins €5.8 million raise for ZeroPhase’s communications software

Ukraine battlefield use underpins €5.8 million raise for ZeroPhase’s communications software ZeroPhase, a Munich-based company building software-defined, mission-proven data links for unmanned defense platforms, has raised €5.8 million in an oversubscribed Seed round to accelerate development and deployment of their adaptive communications layer – preserving sovereign control of critical links

Palantir veterans’ startup Ankar raises €17 million to expand AI-driven IP software into the US

Palantir veterans’ startup Ankar raises €17 million to expand AI-driven IP software into the US Ankar, a London-based AI platform innovating how companies and law firms capture and protect their patents, has raised a €17 million ($20 million) Series A round to grow its team and expand further into the

German startup T-CURX secures €17.7 million to support development of new cancer treatments

German startup T-CURX secures €17.7 million to support development of new cancer treatments Würzburg-based T-CURX today announces the first closing of a €17.7 million Series A to accelerate clinical development of T-CURX non-viral clinical CAR-T therapies in AML and solid tumor indications, as well as advancing T-CURX proprietary non-viral technologies